Want to see HK:3860 full AI Analyst Report?
Top Page
EPS Creative Health Technology Group Limited
(3860)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$0.61
â–¼(-2.70% Downside)
Action:Reiterated
Date:08/29/26
The score is held back primarily by uneven financial performance (return to net losses and volatile revenue), partially offset by improved balance-sheet leverage and a better 2026 cash-flow profile. Technicals add additional pressure with price below key moving averages and negative MACD, while valuation remains challenging due to losses (negative P/E) and only a modest dividend yield.
Positive Factors
Lower Leverage
Materially lower leverage reduces balance-sheet risk and improves financial flexibility. A low debt-to-equity position can help the company withstand operating volatility, preserve borrowing capacity, and retain more options for funding operations or future growth over the next several quarters.
Negative Factors
Revenue Volatility
The uneven revenue pattern makes demand and operating planning less predictable. A meaningful decline followed by only a modest rebound suggests that recent growth has not yet become durable, which can limit margin recovery and make sustainable earnings improvement harder to establish.
Read all positive and negative factors
Positive Factors
Negative Factors
Lower Leverage
Materially lower leverage reduces balance-sheet risk and improves financial flexibility. A low debt-to-equity position can help the company withstand operating volatility, preserve borrowing capacity, and retain more options for funding operations or future growth over the next several quarters.
Read all positive factors
EPS Creative Health Technology Group Limited (3860) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$329.07M
Dividend Yield1.77%
Average Volume (3M)237.33K
Price to Earnings (P/E)―
Beta (1Y)0.30
Revenue Growth-15.95%
EPS Growth-135.81%
CountryHK
Employees133
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Retail
Share Statistics
EPS (TTM)-0.03
Shares Outstanding582,429,800
10 Day Avg. Volume637,000
30 Day Avg. Volume237,333
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.71
Price to Sales (P/S)0.63
P/FCF Ratio11.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EPS Creative Health Technology Group Limited Business Overview & Revenue Model
Company Description
EPS Creative Health Technology Group Limited functions as an investment holding company with diverse operations. It specializes in comprehensive apparel supply chain management, serving clients across Hong Kong, mainland China, Japan, the United S...
How the Company Makes Money
null...
EPS Creative Health Technology Group Limited Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 457.65M | 544.52M | 644.62M | 452.91M | 519.95M |
| Gross Profit | 75.02M | 94.58M | 99.26M | 67.85M | 76.78M |
| EBITDA | 17.63M | 57.53M | -2.96M | -37.88M | -14.53M |
| Net Income | -13.85M | 38.59M | -22.07M | -45.74M | -22.60M |
Balance Sheet | |||||
| Total Assets | 311.39M | 336.85M | 429.88M | 227.49M | 248.92M |
| Cash, Cash Equivalents and Short-Term Investments | 130.49M | 135.69M | 131.51M | 131.47M | 208.14M |
| Total Debt | 4.45M | 57.22M | 11.45M | 73.61M | 9.14M |
| Total Liabilities | 158.67M | 174.33M | 291.70M | 135.85M | 122.22M |
| Stockholders Equity | 105.91M | 120.68M | 65.36M | 87.64M | 131.32M |
Cash Flow | |||||
| Free Cash Flow | 25.11M | -23.63M | -33.60M | -40.52M | 9.99M |
| Operating Cash Flow | 28.21M | -17.92M | -28.57M | -38.11M | 10.05M |
| Investing Cash Flow | -2.98M | 57.20M | -20.40M | -11.38M | 4.57M |
| Financing Cash Flow | -37.51M | -16.78M | 33.66M | -27.75M | 98.11M |
EPS Creative Health Technology Group Limited Technical Analysis
Positive
0.63
Price Trends
0.58
Positive
0.57
Positive
0.61
Negative
Market Momentum
<0.01
Negative
56.71
Neutral
77.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3860, the sentiment is Positive. The current price of 0.63 is above the 20-day moving average (MA) of 0.57, above the 50-day MA of 0.58, and above the 200-day MA of 0.61, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.71 is Neutral, neither overbought nor oversold. The STOCH value of 77.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3860.
EPS Creative Health Technology Group Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.07T | 38.83 | 20.52% | 0.87% | 13.04% | 28.02% | |
72 Outperform | HK$2.25B | 11.02 | 10.15% | 10.00% | -2.94% | -6.03% | |
72 Outperform | HK$3.22B | 6.80 | 8.44% | 7.60% | -4.39% | -12.10% | |
68 Neutral | HK$9.32B | 6.14 | 12.21% | 8.16% | 10.47% | -8.83% | |
63 Neutral | HK$6.79B | 4.33 | 14.22% | 24.52% | -3.55% | -0.62% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$329.07M | -23.02 | -12.65% | 1.77% | -15.95% | -135.81% |
* Consumer Cyclical Sector Average
HK:3860
EPS Creative Health Technology Group Limited
0.61
0.13
27.08%
HK:0709
Giordano International
1.39
-0.12
-7.82%
HK:1368
Xtep International Holdings
3.37
-2.72
-44.64%
HK:3709
EEKA Fashion Holdings Limited
4.61
-2.99
-39.41%
HK:6110
Topsports International Holdings Limited
1.04
-1.61
-60.80%
HK:6288
Fast Retailing Co Ltd Shs Unsponsored Hong Kong Depositary Receipt Repr 1/100th Sh
33.46
8.40
33.52%
EPS Creative Health Technology Group Limited Corporate Events
EPS Creative Health Tech’s Controlling Shareholder to Sell 22% Stake While Retaining Control
Sep 9, 2026
EPS Creative Health Technology Group Limited has announced that controlling shareholder EPS Holdings, Inc. has agreed to sell up to 130 million shares, or 22.32% of the company’s issued share capital, to Hong Kong‑based Wisdoms Group I...
EPS Creative Health Technology Wins Shareholder Approval for 2026 Framework Purchase Deal
Jul 31, 2026
Independent shareholders of EPS Creative Health Technology Group Limited have approved the 2026 Framework Purchase Agreement and its annual caps for the three financial years ending 31 March 2029. The resolution passed unanimously by poll at an ex...
EPS Creative Health Technology Sets AGM to Approve Accounts, Board and Share Issuance Mandate
Jul 20, 2026
EPS Creative Health Technology Group Limited has convened its annual general meeting for 18 August 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements for the year ended 31 March 2026 and vote on the rea...
EPS boosts R&E acquisition payout, adds new major shareholder tied to Japanese supply deal
Jul 15, 2026
EPS Creative Health Technology Group Limited, listed in Hong Kong, operates in the health and wellness products sector, with a focus on distributing and marketing consumer health goods. Through its stake in RE Corporation Limited and an exclusive ...
EPS Creative Health Tech Calls EGM to Approve 2026 Framework Purchase Deal
Jul 14, 2026
EPS Creative Health Technology Group Limited has called an extraordinary general meeting in Hong Kong on 31 July 2026 for shareholders to vote on approving a 2026 Framework Purchase Agreement related to its continuing connected transactions, inclu...
EPS Creative Health Sets July Extraordinary General Meeting and Book Closure
Jul 13, 2026
EPS Creative Health Technology Group Limited has scheduled an extraordinary general meeting for 10:00 a.m. on 31 July 2026 at Dah Sing Financial Centre in Wanchai, Hong Kong. The meeting will consider matters related to a 2026 Framework Purchase A...
EPS Creative Health Technology Swings to Loss and Halts Final Dividend
Jun 29, 2026
EPS Creative Health Technology Group Limited, a Cayman Islands–incorporated health technology group listed in Hong Kong, offers technology-based health and wellness solutions through its subsidiaries. The company operates within the broader ...
EPS Creative Health Technology delays shareholder circular on 2026 framework deal
Jun 26, 2026
EPS Creative Health Technology Group Limited has delayed the distribution of a shareholder circular related to its 2026 Framework Purchase Agreement, which includes proposed annual caps for 2027-2029. The circular, originally scheduled for dispatc...
EPS Creative Health Technology Schedules Board Meeting to Approve Annual Results and Consider Dividend
Jun 15, 2026
EPS Creative Health Technology Group Limited has scheduled a board meeting for 29 June 2026 to review and approve the audited annual results for the financial year ended 31 March 2026. The board will also consider whether to recommend a final divi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.